data_1gyz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gyz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 CA-C-O 120.619 0.247 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.625 HD11 ' HG1' ' A' ' 76' ' ' THR . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.625 ' HG1' HD11 ' A' ' 72' ' ' LEU . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 63' ' ' ILE . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 90' ' ' ARG . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HA ' HD21 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HA ' ' HH ' ' A' ' 74' ' ' TYR . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 76' ' ' THR . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.407 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.407 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.495 -1.144 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 76' ' ' THR . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.547 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.547 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp . . . . . 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HH ' ' HA ' ' A' ' 90' ' ' ARG . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.532 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.495 ' HA ' ' HH ' ' A' ' 74' ' ' TYR . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.477 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 90' ' ' ARG 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 89' ' ' ASP . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 63' ' ' ILE . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.401 HD22 HD11 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 79' ' ' ASN . 63.9 tp . . . . . 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 76' ' ' THR . 2.0 p30 -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 95' ' ' ASP 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 93' ' ' LEU 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 60' ' ' ILE 0.311 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 120.898 0.38 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.426 ' H ' ' H ' ' A' ' 91' ' ' LYS . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' H ' ' H ' ' A' ' 90' ' ' ARG . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.475 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.466 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HG13 ' A' ' 63' ' ' ILE 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp . . . . . 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.514 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.514 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' CD1' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' CD1' ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.668 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 93' ' ' LEU . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.401 0 CA-C-O 120.791 0.329 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.456 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt . . . . . 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD13 ' HZ3' ' A' ' 112' ' ' LYS . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.42 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ3' HD13 ' A' ' 72' ' ' LEU . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.434 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 26.7 m-90 . . . . . 0 CA--C 1.494 -1.179 0 CA-C-O 121.791 0.805 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.5 -61.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.522 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.625 HD11 ' HG1' ' A' ' 76' ' ' THR . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.625 ' HG1' HD11 ' A' ' 72' ' ' LEU . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.434 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.3 -72.11 0.68 Allowed 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -78.18 -37.84 44.82 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.183 -144.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.88 -0.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -166.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.556 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' H1 ' HD12 ' A' ' 60' ' ' ILE . 6.7 m-90 . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.442 0.163 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.45 HD12 ' H1 ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -154.49 -60.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -173.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 63' ' ' ILE . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 90' ' ' ARG . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HA ' HD21 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HA ' ' HH ' ' A' ' 74' ' ' TYR . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.431 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.61 -77.24 0.09 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -118.83 -24.22 6.7 Favored 'General case' 0 CA--C 1.473 -1.998 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.328 -151.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.252 12.1 t 81.07 40.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.26 1.65 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.68 168.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.435 ' HB3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.721 0.772 . . . . 0.0 109.68 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -151.5 150.78 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 76' ' ' THR . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.407 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.407 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp -72.17 -36.73 69.35 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 67.93 53.89 0.64 Allowed 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.431 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.61 -7.61 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 101.334 -3.58 . . . . 0.0 101.334 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.629 173.113 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 18.8 m-90 . . . . . 0 CA--C 1.497 -1.058 0 CA-C-O 121.397 0.618 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.39 -63.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.115 -163.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 76' ' ' THR . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.41 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.547 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.547 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp -70.7 -38.08 73.64 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 71.0 51.51 0.29 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.95 -7.38 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-O 117.267 -1.349 . . . . 0.0 110.151 173.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 66.0 m95 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -148.49 44.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.068 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 173.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HH ' ' HA ' ' A' ' 90' ' ' ARG . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.532 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.495 ' HA ' ' HH ' ' A' ' 74' ' ' TYR . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp -103.8 -76.94 0.58 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -64.69 -59.07 4.68 Favored 'General case' 0 CA--C 1.487 -1.463 0 O-C-N 124.925 1.39 . . . . 0.0 111.423 -145.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.73 -18.94 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -175.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 C--O 1.259 1.596 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 11.7 m-90 . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.05 -63.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.234 -167.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.34 -38.95 59.88 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 71.16 50.71 0.29 Allowed 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.7 -5.17 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 C--O 1.261 1.678 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.863 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 21.3 m95 . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.57 -64.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -162.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' H ' ' H ' ' A' ' 90' ' ' ARG 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 89' ' ' ASP . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.76 -75.85 0.6 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -70.47 -35.37 73.26 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.76 -144.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.61 -21.55 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -167.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 C--O 1.262 1.742 0 C-N-CA 116.218 -2.193 . . . . 0.0 107.679 172.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.405 ' H1 ' HD12 ' A' ' 60' ' ' ILE . 8.0 m95 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.405 HD12 ' H1 ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -141.5 -60.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 O-C-N 121.835 -0.54 . . . . 0.0 109.692 -171.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 63' ' ' ILE . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.401 HD22 HD11 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 79' ' ' ASN . 63.9 tp -77.62 -39.47 45.19 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 67.51 49.74 0.98 Allowed 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.427 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.3 p -91.27 -7.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 166.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.261 1.691 0 CA-C-O 117.245 -1.36 . . . . 0.0 110.839 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.595 ' CG ' ' HA ' ' A' ' 89' ' ' ASP 0.256 3.5 t90 . . . . . 0 CA--C 1.5 -0.972 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.52 -58.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.228 0 CA-C-N 114.281 -1.327 . . . . 0.0 114.387 168.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 ' CD1' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 76' ' ' THR . 2.0 p30 -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' CZ2' ' A' ' 59' ' ' TRP . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' CG ' ' A' ' 59' ' ' TRP . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' N ' ' HB3' ' A' ' 59' ' ' TRP . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.525 ' H ' ' CB ' ' A' ' 59' ' ' TRP 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 59' ' ' TRP 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 93' ' ' LEU 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -71.6 -81.53 0.05 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.89 -14.03 14.03 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -153.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.4 t 67.59 37.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -167.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.26 1.627 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 90' ' ' ARG . 15.2 p90 . . . . . 0 CA--C 1.458 -2.57 0 N-CA-C 101.21 -3.626 . . . . 0.0 101.21 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 60' ' ' ILE 0.311 0.1 OUTLIER -131.07 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 O-C-N 125.062 1.476 . . . . 0.0 114.365 -159.836 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.422 ' HA ' ' CG ' ' A' ' 59' ' ' TRP . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp -80.72 -27.29 36.96 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 65.66 39.48 4.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.269 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.95 -3.51 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.176 171.015 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -161.39 -62.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -168.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.426 ' H ' ' H ' ' A' ' 91' ' ' LYS . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' H ' ' H ' ' A' ' 90' ' ' ARG . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.475 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -73.19 -39.28 65.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 70.6 49.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.183 -1.371 . . . . 0.0 107.363 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.65 -9.0 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 164.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 . . . . . 0 C--O 1.261 1.673 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 173.559 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.2 m95 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.51 -62.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -165.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.66 -39.61 70.19 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 69.86 52.26 0.41 Allowed 'General case' 0 N--CA 1.433 -1.292 0 O-C-N 125.11 1.506 . . . . 0.0 107.115 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.93 -9.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 164.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.764 176.091 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.745 ' CD2' ' HA ' ' A' ' 89' ' ' ASP . 1.8 t90 . . . . . 0 CA--C 1.485 -1.527 1 N-CA-C 96.947 -5.205 . . . . 0.0 96.947 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.614 HD12 ' H1 ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 -69.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.365 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.218 175.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.466 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.745 ' HA ' ' CD2' ' A' ' 59' ' ' TRP . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.571 ' H ' ' CB ' ' A' ' 59' ' ' TRP 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.5 ' HB ' ' CZ3' ' A' ' 59' ' ' TRP . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.636 ' HB3' ' CD2' ' A' ' 59' ' ' TRP 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' CB ' ' H2 ' ' A' ' 59' ' ' TRP 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -84.95 -34.39 22.46 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 64.18 51.04 2.26 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.878 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.5 -11.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.261 1.684 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.327 -176.563 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' CG ' ' O ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.939 1.352 . . . . 0.0 107.97 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER -141.56 -77.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 117.34 -1.744 . . . . 0.0 113.729 171.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HA ' ' CG ' ' A' ' 59' ' ' TRP . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HE2' ' H2 ' ' A' ' 59' ' ' TRP . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.78 -63.05 1.14 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -157.86 -69.64 0.09 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.33 -26.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 . . . . . 0 C--O 1.26 1.628 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.855 -165.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.442 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 15.0 m-90 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 ' H1 ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -147.47 -57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -172.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.442 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -78.42 -34.14 48.14 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 70.86 42.14 0.8 Allowed 'General case' 0 CA--C 1.492 -1.286 0 O-C-N 124.813 1.32 . . . . 0.0 107.964 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.3 -9.75 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 C--O 1.259 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.356 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.472 ' CG ' ' O ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 CA-C-O 122.937 1.351 . . . . 0.0 108.129 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER -149.1 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 C-N-CA 116.261 -2.176 . . . . 0.0 113.02 167.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HE2' ' H2 ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp -78.87 -36.54 42.06 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 64.4 49.21 2.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.231 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.62 -8.7 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 168.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 C--O 1.259 1.577 0 CA-C-O 117.185 -1.388 . . . . 0.0 111.5 -179.166 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.514 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -141.03 -86.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -156.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.514 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' CD1' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' CD1' ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.668 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 93' ' ' LEU . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.07 -35.53 20.21 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.458 HE21 HE21 ' A' ' 118' ' ' GLN . 10.6 tp60 71.48 36.87 1.22 Allowed 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -88.05 -14.08 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.458 HE21 HE21 ' A' ' 116' ' ' GLN . 4.2 pp0? . . . . . 0 C--O 1.261 1.669 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.532 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.402 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 20.8 m-90 . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.04 -65.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.142 -168.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.402 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt -113.63 -61.15 1.78 Allowed 'General case' 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -90.44 -30.76 17.15 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 110.092 -3.231 . . . . 0.0 102.942 -146.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.65 -9.08 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.262 1.719 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.465 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 5.5 m-90 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 120.723 0.297 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 ' H1 ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -150.22 -56.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -172.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.465 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt -76.99 -27.19 54.62 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 63.75 47.63 3.55 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.104 -1.862 . . . . 0.0 107.672 -168.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.73 -60.06 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.642 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.48 -1.718 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER -159.17 -76.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.471 156.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD13 ' HZ3' ' A' ' 112' ' ' LYS . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ3' HD13 ' A' ' 72' ' ' LEU . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp -82.06 -32.99 30.11 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 63.75 45.43 4.49 Favored 'General case' 0 CA--C 1.498 -1.019 0 O-C-N 124.874 1.359 . . . . 0.0 108.346 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.05 -7.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.558 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 CA-C-O 120.619 0.247 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 89' ' ' ASP 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 94' ' ' ALA . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' HD22 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.484 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 88' ' ' LEU . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 94' ' ' ALA . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 88' ' ' LEU . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 93' ' ' LEU . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 91' ' ' LYS . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.44 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.44 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.495 -1.144 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 94' ' ' ALA . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.561 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.561 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp . . . . . 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 . . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.411 HH12 HH11 ' A' ' 99' ' ' ARG . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 60' ' ' ILE . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 HH12 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' ALA . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 89' ' ' ASP 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' A' ' 94' ' ' ALA . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.311 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 94' ' ' ALA 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 120.898 0.38 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.698 HD13 ' H ' ' A' ' 88' ' ' LEU 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.769 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 ' HB3' ' A' ' 89' ' ' ASP 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 89' ' ' ASP 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 60' ' ' ILE 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 104' ' ' PHE 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 63' ' ' ILE 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 93' ' ' LEU . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 63' ' ' ILE 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 111' ' ' VAL . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 78' ' ' ILE . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 89' ' ' ASP 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.441 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp . . . . . 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.754 HH21 HG21 ' A' ' 98' ' ' VAL . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 88' ' ' LEU . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 93' ' ' LEU . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.724 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG21 HH21 ' A' ' 62' ' ' ARG . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.401 0 CA-C-O 120.791 0.329 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.426 HG21 HD23 ' A' ' 81' ' ' LEU . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt . . . . . 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 94' ' ' ALA . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 77' ' ' PHE . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 72' ' ' LEU . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 63' ' ' ILE 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' HA ' HH11 ' A' ' 99' ' ' ARG . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 95' ' ' ASP . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 63' ' ' ILE 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 26.7 m-90 . . . . . 0 CA--C 1.494 -1.179 0 CA-C-O 121.791 0.805 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.5 -61.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.522 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 89' ' ' ASP 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.3 -72.11 0.68 Allowed 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -78.18 -37.84 44.82 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.183 -144.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.88 -0.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -166.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.556 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 6.7 m-90 . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.442 0.163 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -154.49 -60.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -173.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 94' ' ' ALA . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' HD22 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.484 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 88' ' ' LEU . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.61 -77.24 0.09 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -118.83 -24.22 6.7 Favored 'General case' 0 CA--C 1.473 -1.998 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.328 -151.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.252 12.1 t 81.07 40.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.26 1.65 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.68 168.851 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.534 ' HB3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.721 0.772 . . . . 0.0 109.68 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -151.5 150.78 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 94' ' ' ALA . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 88' ' ' LEU . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 93' ' ' LEU . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 91' ' ' LYS . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.44 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.44 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp -72.17 -36.73 69.35 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 67.93 53.89 0.64 Allowed 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.431 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.61 -7.61 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 101.334 -3.58 . . . . 0.0 101.334 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.629 173.113 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 18.8 m-90 . . . . . 0 CA--C 1.497 -1.058 0 CA-C-O 121.397 0.618 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.39 -63.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.115 -163.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 94' ' ' ALA . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.416 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.561 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.561 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp -70.7 -38.08 73.64 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 71.0 51.51 0.29 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.95 -7.38 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-O 117.267 -1.349 . . . . 0.0 110.151 173.471 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 66.0 m95 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE 0.256 0.0 OUTLIER -148.49 44.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.068 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 173.488 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.411 HH12 HH11 ' A' ' 99' ' ' ARG . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 60' ' ' ILE . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 HH12 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp -103.8 -76.94 0.58 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -64.69 -59.07 4.68 Favored 'General case' 0 CA--C 1.487 -1.463 0 O-C-N 124.925 1.39 . . . . 0.0 111.423 -145.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -83.73 -18.94 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 C--O 1.259 1.596 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.593 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.7 m-90 . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.05 -63.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.234 -167.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.409 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.34 -38.95 59.88 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 71.16 50.71 0.29 Allowed 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.7 -5.17 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 C--O 1.261 1.678 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.863 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 21.3 m95 . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.57 -64.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -162.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' ALA . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 89' ' ' ASP 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.76 -75.85 0.6 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -70.47 -35.37 73.26 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.76 -144.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.61 -21.55 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -167.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 C--O 1.262 1.742 0 C-N-CA 116.218 -2.193 . . . . 0.0 107.679 172.955 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' HD13 ' A' ' 60' ' ' ILE . 8.0 m95 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.5 -60.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 O-C-N 121.835 -0.54 . . . . 0.0 109.692 -171.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -77.62 -39.47 45.19 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 67.51 49.74 0.98 Allowed 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.427 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.3 p -91.27 -7.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 166.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.261 1.691 0 CA-C-O 117.245 -1.36 . . . . 0.0 110.839 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.767 ' CE2' ' HB3' ' A' ' 93' ' ' LEU 0.256 3.5 t90 . . . . . 0 CA--C 1.5 -0.972 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.52 -58.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.228 0 CA-C-N 114.281 -1.327 . . . . 0.0 114.387 168.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.632 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' ' CZ2' ' A' ' 59' ' ' TRP . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.617 ' HA ' ' CD2' ' A' ' 59' ' ' TRP . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.58 ' H ' ' HB3' ' A' ' 59' ' ' TRP 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.767 ' HB3' ' CE2' ' A' ' 59' ' ' TRP 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' A' ' 94' ' ' ALA . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -71.6 -81.53 0.05 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.89 -14.03 14.03 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -153.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.4 t 67.59 37.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -167.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.26 1.627 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 90' ' ' ARG . 15.2 p90 . . . . . 0 CA--C 1.458 -2.57 0 N-CA-C 101.21 -3.626 . . . . 0.0 101.21 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.311 0.1 OUTLIER -131.07 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 O-C-N 125.062 1.476 . . . . 0.0 114.365 -159.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' CG ' ' A' ' 59' ' ' TRP . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 94' ' ' ALA 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp -80.72 -27.29 36.96 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 65.66 39.48 4.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.269 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.95 -3.51 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.176 171.015 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.6 m-90 . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -161.39 -62.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -168.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.698 HD13 ' H ' ' A' ' 88' ' ' LEU 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.769 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 ' HB3' ' A' ' 89' ' ' ASP 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -73.19 -39.28 65.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 70.6 49.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.183 -1.371 . . . . 0.0 107.363 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.65 -9.0 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 164.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 . . . . . 0 C--O 1.261 1.673 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 173.559 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 4.2 m95 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.51 -62.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -165.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 89' ' ' ASP 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.66 -39.61 70.19 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 69.86 52.26 0.41 Allowed 'General case' 0 N--CA 1.433 -1.292 0 O-C-N 125.11 1.506 . . . . 0.0 107.115 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.93 -9.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 164.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.764 176.091 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.839 ' CD2' ' HA ' ' A' ' 89' ' ' ASP . 1.8 t90 . . . . . 0 CA--C 1.485 -1.527 1 N-CA-C 96.947 -5.205 . . . . 0.0 96.947 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -138.26 -69.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.365 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.218 175.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.839 ' HA ' ' CD2' ' A' ' 59' ' ' TRP . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.687 ' H ' ' HB2' ' A' ' 59' ' ' TRP 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.489 ' HB ' ' CZ3' ' A' ' 59' ' ' TRP . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.779 ' HB3' ' CD2' ' A' ' 59' ' ' TRP 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 63' ' ' ILE 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 93' ' ' LEU . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -84.95 -34.39 22.46 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 64.18 51.04 2.26 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.878 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.5 -11.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 C--O 1.261 1.684 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.327 -176.563 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.505 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.939 1.352 . . . . 0.0 107.97 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER -141.56 -77.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 117.34 -1.744 . . . . 0.0 113.729 171.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 63' ' ' ILE 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 111' ' ' VAL . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.78 -63.05 1.14 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -157.86 -69.64 0.09 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.436 ' H ' ' H ' ' A' ' 118' ' ' GLN . 7.3 p -162.33 -26.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.436 ' H ' ' H ' ' A' ' 117' ' ' VAL . 15.6 pt20 . . . . . 0 C--O 1.26 1.628 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.855 -165.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.464 ' N ' HD13 ' A' ' 60' ' ' ILE . 15.0 m-90 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -147.47 -57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -172.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 78' ' ' ILE . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 89' ' ' ASP 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -78.42 -34.14 48.14 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 70.86 42.14 0.8 Allowed 'General case' 0 CA--C 1.492 -1.286 0 O-C-N 124.813 1.32 . . . . 0.0 107.964 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.3 -9.75 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 C--O 1.259 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.356 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.504 ' HB2' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 CA-C-O 122.937 1.351 . . . . 0.0 108.129 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER -149.1 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 C-N-CA 116.261 -2.176 . . . . 0.0 113.02 167.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.441 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp -78.87 -36.54 42.06 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 64.4 49.21 2.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.231 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.62 -8.7 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 168.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 C--O 1.259 1.577 0 CA-C-O 117.185 -1.388 . . . . 0.0 111.5 -179.166 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -141.03 -86.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -156.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.754 HH21 HG21 ' A' ' 98' ' ' VAL . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 88' ' ' LEU . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 93' ' ' LEU . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.724 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG21 HH21 ' A' ' 62' ' ' ARG . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.07 -35.53 20.21 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 71.48 36.87 1.22 Allowed 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -88.05 -14.08 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? . . . . . 0 C--O 1.261 1.669 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.532 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.04 -65.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.142 -168.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.426 HG21 HD23 ' A' ' 81' ' ' LEU . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt -113.63 -61.15 1.78 Allowed 'General case' 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -90.44 -30.76 17.15 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 110.092 -3.231 . . . . 0.0 102.942 -146.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.65 -9.08 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.262 1.719 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 5.5 m-90 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 120.723 0.297 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -150.22 -56.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -172.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 94' ' ' ALA . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 77' ' ' PHE . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 72' ' ' LEU . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 63' ' ' ILE 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.466 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' HA ' HH11 ' A' ' 99' ' ' ARG . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 95' ' ' ASP . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt -76.99 -27.19 54.62 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 63.75 47.63 3.55 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.104 -1.862 . . . . 0.0 107.672 -168.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.73 -60.06 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.642 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.525 ' HB2' HD12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.48 -1.718 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER -159.17 -76.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.471 156.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 63' ' ' ILE 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp -82.06 -32.99 30.11 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 63.75 45.43 4.49 Favored 'General case' 0 CA--C 1.498 -1.019 0 O-C-N 124.874 1.359 . . . . 0.0 108.346 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.05 -7.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.558 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 CA-C-O 120.619 0.247 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 89' ' ' ASP 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 94' ' ' ALA . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' HD22 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.484 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 88' ' ' LEU . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 94' ' ' ALA . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 88' ' ' LEU . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 93' ' ' LEU . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 91' ' ' LYS . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.44 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.44 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.495 -1.144 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 94' ' ' ALA . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.561 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.561 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp . . . . . 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 60' ' ' ILE 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.411 HH12 HH11 ' A' ' 99' ' ' ARG . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 60' ' ' ILE . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 HH12 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' ALA . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 89' ' ' ASP 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.523 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.0 p30 -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' A' ' 94' ' ' ALA . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.311 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 94' ' ' ALA 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 120.898 0.38 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.698 HD13 ' H ' ' A' ' 88' ' ' LEU 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.769 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 ' HB3' ' A' ' 89' ' ' ASP 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 89' ' ' ASP 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HE3' HD11 ' A' ' 60' ' ' ILE 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 104' ' ' PHE 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 63' ' ' ILE 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 93' ' ' LEU . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 63' ' ' ILE 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 111' ' ' VAL . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 78' ' ' ILE . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 89' ' ' ASP 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.441 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp . . . . . 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.754 HH21 HG21 ' A' ' 98' ' ' VAL . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 88' ' ' LEU . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 93' ' ' LEU . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.724 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG21 HH21 ' A' ' 62' ' ' ARG . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.401 0 CA-C-O 120.791 0.329 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.426 HG21 HD23 ' A' ' 81' ' ' LEU . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt . . . . . 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 94' ' ' ALA . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 77' ' ' PHE . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 72' ' ' LEU . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 63' ' ' ILE 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' HA ' HH11 ' A' ' 99' ' ' ARG . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 95' ' ' ASP . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt . . . . . 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 63' ' ' ILE 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 26.7 m-90 . . . . . 0 CA--C 1.494 -1.179 0 CA-C-O 121.791 0.805 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -147.5 -61.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.522 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.65 49.21 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.14 36.56 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 mt -78.74 -39.51 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.525 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -63.69 -42.77 97.96 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.52 65.42 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.748 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.63 24.53 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.997 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -91.63 -7.38 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.422 -0.173 . . . . 0.0 110.791 -166.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -80.11 -4.54 53.26 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.404 0.282 . . . . 0.0 110.549 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.88 75.01 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -86.86 -50.36 6.77 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.27 -12.7 1.84 Allowed Glycine 0 N--CA 1.435 -1.393 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.47 151.51 38.03 Favored 'General case' 0 CA--C 1.475 -1.925 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.57 20.14 11.12 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 5.3 t80 84.8 -24.22 0.15 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 126.43 1.892 . . . . 0.0 108.641 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 m -82.32 -38.27 24.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.904 0.775 . . . . 0.0 110.255 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -86.19 -25.23 25.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -64.1 -40.15 95.59 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -38.69 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.33 1.452 . . . . 0.0 110.815 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.16 -38.32 43.88 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.427 1.108 . . . . 0.0 109.201 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.78 72.66 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.3 mt -64.25 -37.59 88.01 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 118.453 1.126 . . . . 0.0 110.876 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -28.07 48.4 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -72.17 -30.59 65.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.6 64.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.92 28.49 8.23 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 106.662 -2.575 . . . . 0.0 106.662 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -128.95 102.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 -172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.98 91.24 8.69 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.94 -166.98 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER 44.52 45.37 7.7 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 128.499 2.719 . . . . 0.0 111.442 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -101.61 -9.8 20.62 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -166.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.4 mttt 136.23 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.802 1 N-CA-C 99.862 -4.125 . . . . 0.0 99.862 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 82.3 22.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 127.194 2.198 . . . . 0.0 107.662 161.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 89' ' ' ASP 0.345 0.0 OUTLIER -103.74 -28.76 11.47 Favored 'General case' 0 CA--C 1.443 -3.173 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 154.667 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.6 -14.95 15.52 Favored 'General case' 0 CA--C 1.474 -1.962 0 C-N-CA 127.725 2.41 . . . . 0.0 111.772 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -60.66 -55.47 32.82 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 165.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.417 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -67.73 -26.26 66.06 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -173.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.32 67.28 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.735 -0.603 . . . . 0.0 112.354 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -43.19 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -95.31 -21.6 18.3 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.253 0.621 . . . . 0.0 110.162 -157.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -125.04 80.41 64.13 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 124.262 1.025 . . . . 0.0 109.444 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -75.94 -7.09 18.06 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.93 2.42 . . . . 0.0 110.807 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -72.23 -51.75 19.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -78.81 -31.39 45.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.68 -46.5 63.86 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.053 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -67.2 -19.55 65.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.844 0.747 . . . . 0.0 112.905 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -74.54 -42.81 58.17 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 118.756 0.707 . . . . 0.0 110.232 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.19 -40.59 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 t -62.93 -39.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 C-N-CA 124.621 1.168 . . . . 0.0 109.719 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.23 -39.6 94.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.145 0.578 . . . . 0.0 110.539 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -71.18 -34.08 70.58 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 122.242 0.217 . . . . 0.0 111.043 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.13 -10.16 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 123.689 0.796 . . . . 0.0 109.112 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.85 -36.82 30.93 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -41.29 24.24 Favored 'General case' 0 CA--C 1.476 -1.881 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.206 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.85 84.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.973 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.3 -72.11 0.68 Allowed 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -78.18 -37.84 44.82 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.183 -144.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.88 -0.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -166.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.556 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' HB3' ' H ' ' A' ' 92' ' ' ILE . 6.7 m-90 . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.442 0.163 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -154.49 -60.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.327 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -173.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.17 -3.01 57.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -73.63 -44.19 57.58 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 94' ' ' ALA . 4.5 mt -71.51 -44.74 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 C-N-CA 126.66 1.984 . . . . 0.0 109.229 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -59.4 -41.65 89.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 123.983 0.802 . . . . 0.0 109.419 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.06 -22.69 44.96 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.21 -176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.13 -31.4 44.08 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.505 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -92.27 -14.71 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -166.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.61 103.96 7.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.32 -45.86 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -87.82 -41.86 12.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.073 -172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.99 -8.83 5.73 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 105.388 -3.085 . . . . 0.0 105.388 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.53 139.94 44.13 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -124.52 22.62 8.34 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.987 -169.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.5 t80 91.0 -36.97 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.981 2.113 . . . . 0.0 108.694 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.1 p -79.57 -33.25 41.9 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 118.54 0.609 . . . . 0.0 110.553 -168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' HD22 ' A' ' 79' ' ' ASN . 1.0 OUTLIER -92.32 -21.43 20.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.83 -46.42 85.14 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -44.54 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 126.796 2.039 . . . . 0.0 109.103 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.484 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.2 p30 -76.7 -46.72 24.4 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 112.136 -170.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.97 -22.64 78.44 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.81 -171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -63.13 -36.37 83.37 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 117.472 0.636 . . . . 0.0 110.862 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.99 -30.82 61.27 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -65.52 -33.85 76.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.51 -64.21 1.12 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 129.37 29.66 0.7 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 88' ' ' LEU . 41.1 mm -86.44 -69.72 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.67 46.6 25.61 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.076 1.75 . . . . 0.0 110.863 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -125.29 -10.62 6.98 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -162.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.9 178.73 7.21 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-O 121.752 0.786 . . . . 0.0 109.57 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 120.25 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 100.903 -3.739 . . . . 0.0 100.903 171.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -178.01 127.99 0.13 Allowed 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 79.79 76.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 C-N-CA 127.179 2.191 . . . . 0.0 107.92 164.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.281 0.0 OUTLIER 177.35 -35.04 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.66 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 174.934 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.322 . . -43.03 -34.37 1.0 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.259 -2.701 . . . . 0.0 111.264 155.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.72 -51.4 69.5 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.31 69.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.975 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -28.71 69.81 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.77 -55.65 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.59 -29.93 29.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 124.292 1.037 . . . . 0.0 112.675 -160.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.7 81.27 55.01 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 123.339 0.656 . . . . 0.0 109.653 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.83 -6.72 16.19 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.675 2.25 . . . . 0.0 110.086 -171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -70.24 -56.25 7.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.89 -35.1 72.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -52.98 -50.51 64.0 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.66 -14.5 60.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 118.384 0.538 . . . . 0.0 111.818 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -77.34 -36.72 53.59 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 118.628 0.649 . . . . 0.0 110.218 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.31 -34.77 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.7 -39.94 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -65.91 -31.89 73.08 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -64.58 -57.03 10.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.2 t -79.79 5.05 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 C-N-CA 128.371 2.668 . . . . 0.0 110.891 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -77.77 -55.36 5.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 O-C-N 120.392 -1.443 . . . . 0.0 108.007 164.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.39 -41.72 27.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.389 1.09 . . . . 0.0 109.386 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -17.03 63.16 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.007 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.61 -77.24 0.09 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.845 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -118.83 -24.22 6.7 Favored 'General case' 0 CA--C 1.473 -1.998 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.328 -151.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . 0.252 12.1 t 81.07 40.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 N-CA-C 100.753 -3.795 . . . . 0.0 100.753 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.26 1.65 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.68 168.851 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.534 ' HB3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.721 0.772 . . . . 0.0 109.68 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -151.5 150.78 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.46 -13.7 0.53 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.625 2.37 . . . . 0.0 111.57 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -87.15 -19.28 28.69 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 129.849 3.26 . . . . 0.0 106.666 -175.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 94' ' ' ALA . 14.0 mt -87.17 -38.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -62.47 -31.6 72.35 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.21 -24.34 51.32 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.18 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 -39.42 18.73 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.98 1.58 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 120.253 0.073 . . . . 0.0 111.079 -163.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -72.84 -14.85 61.59 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.151 0.58 . . . . 0.0 111.19 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.01 83.06 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 123.395 0.678 . . . . 0.0 109.548 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -75.81 -48.34 22.04 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -6.12 5.81 Favored Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.73 149.48 41.78 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -126.75 22.59 6.83 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.444 -173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 t80 85.09 -27.13 0.09 Allowed 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.821 1.648 . . . . 0.0 107.953 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.4 t -82.19 -39.31 23.32 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -87.0 -25.02 24.46 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -60.78 -45.98 92.25 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -40.13 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 125.724 1.61 . . . . 0.0 109.529 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.72 -49.5 15.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 121.22 0.533 . . . . 0.0 111.648 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.36 -20.51 78.75 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.332 -169.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 -46.83 88.69 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 117.875 0.837 . . . . 0.0 109.793 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.42 -32.75 74.32 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 124.037 0.935 . . . . 0.0 109.162 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.07 -35.58 80.15 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.47 59.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.95 28.31 1.89 Allowed Glycine 0 CA--C 1.491 -1.445 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 88' ' ' LEU . 72.5 mt -99.42 -64.86 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 103.309 -2.849 . . . . 0.0 103.309 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 57.36 39.96 27.91 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.168 1.787 . . . . 0.0 109.745 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -127.75 127.22 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -166.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 93' ' ' LEU . 7.4 m-20 -139.94 -141.91 0.15 Allowed 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 76.79 -179.2 0.14 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 125.41 1.484 . . . . 0.0 108.088 -169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 17.8 ptpt -100.72 16.08 26.14 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.93 -6.18 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 101.26 -3.607 . . . . 0.0 101.26 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.353 0.0 OUTLIER -118.13 -41.77 2.85 Favored 'General case' 0 CA--C 1.43 -3.637 0 C-N-CA 117.862 -1.535 . . . . 0.0 107.725 168.371 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 91' ' ' LYS . . . -83.2 5.47 22.74 Favored 'General case' 0 N--CA 1.418 -2.05 0 O-C-N 125.201 1.563 . . . . 0.0 108.782 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.39 -48.49 81.54 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 154.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -23.98 63.42 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.492 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.61 -43.04 89.48 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 119.142 0.883 . . . . 0.0 112.141 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.44 ' HB ' HH11 ' A' ' 99' ' ' ARG . 0.4 OUTLIER -102.46 -42.06 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -173.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.44 HH11 ' HB ' ' A' ' 98' ' ' VAL . 3.5 mpt_? -90.66 -25.62 20.01 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.736 -162.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -123.91 74.36 56.45 Favored Pre-proline 0 C--N 1.358 0.971 0 CA-C-N 118.738 0.699 . . . . 0.0 109.951 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.81 -4.86 15.43 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 123.705 2.937 . . . . 0.0 110.117 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -72.22 -47.8 47.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.86 -34.43 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.7 -44.5 69.85 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -68.1 -28.09 67.04 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 118.741 0.7 . . . . 0.0 111.231 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -71.72 -38.81 70.46 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 122.875 0.47 . . . . 0.0 110.66 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.85 -42.55 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.58 -39.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 C-N-CA 125.08 1.352 . . . . 0.0 109.742 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -65.46 -40.14 92.82 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.06 0.544 . . . . 0.0 109.602 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -73.97 -34.87 64.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 110.661 -0.125 . . . . 0.0 110.661 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.8 t -88.38 -3.12 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 C-N-CA 124.806 1.242 . . . . 0.0 110.193 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -31.14 61.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -96.12 -28.69 14.47 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 121.704 0.764 . . . . 0.0 110.527 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.8 -24.41 48.81 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 tp -72.17 -36.73 69.35 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 67.93 53.89 0.64 Allowed 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.431 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.61 -7.61 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 101.334 -3.58 . . . . 0.0 101.334 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.629 173.113 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 18.8 m-90 . . . . . 0 CA--C 1.497 -1.058 0 CA-C-O 121.397 0.618 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.39 -63.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.115 -163.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.88 -10.83 46.5 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -21.63 50.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 94' ' ' ALA . 29.8 mt -78.44 -41.86 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 C-N-CA 125.47 1.508 . . . . 0.0 107.74 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -64.73 -37.72 88.54 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.48 -23.0 53.79 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.26 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.19 -41.98 39.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.683 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.9 m -92.56 -4.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -161.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -81.34 -0.78 42.69 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -79.68 -51.18 9.56 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.54 -14.04 3.95 Favored Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 105.064 -3.215 . . . . 0.0 105.064 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 96.1 mt -73.23 144.68 46.64 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -123.41 24.52 8.63 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.829 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.263 12.7 t80 84.0 -28.66 0.09 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.749 1.619 . . . . 0.0 108.975 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -83.5 -41.65 17.75 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 123.367 0.667 . . . . 0.0 110.915 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 p -86.23 -21.27 27.51 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -65.03 -42.9 93.93 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -40.07 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.4 1.48 . . . . 0.0 109.471 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.13 -48.43 13.21 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.264 0.554 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.76 -21.87 78.04 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.864 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.84 -46.57 88.91 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 117.463 0.631 . . . . 0.0 110.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -72.56 -25.42 61.35 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 123.989 0.916 . . . . 0.0 108.947 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -70.7 -34.34 71.84 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 -47.84 42.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.55 31.82 1.73 Allowed Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.624 -2.191 . . . . 0.0 107.624 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.9 mt -100.5 -62.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 32.04 71.67 0.08 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 128.378 2.671 . . . . 0.0 111.425 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.2 tp -125.02 -13.62 6.79 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -161.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.05 -178.98 3.55 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.764 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 101.69 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.759 0 C-N-CA 129.323 3.049 . . . . 0.0 103.282 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -175.52 118.87 0.17 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.416 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 78.46 81.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 126.341 1.856 . . . . 0.0 108.65 157.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 176.13 -36.08 0.01 OUTLIER 'General case' 0 CA--C 1.458 -2.569 1 N-CA-C 98.497 -4.631 . . . . 0.0 98.497 -179.265 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 63' ' ' ILE 0.307 . . -52.18 -31.61 32.43 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 111.147 -2.751 . . . . 0.0 110.253 162.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.56 -55.24 33.03 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -21.15 65.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.699 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.95 87.16 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 120.591 -1.318 . . . . 0.0 110.978 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.561 ' HB ' HH11 ' A' ' 99' ' ' ARG . 9.2 t -91.07 -63.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.561 HH11 ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -82.86 -24.77 33.08 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -163.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -123.55 71.68 48.64 Favored Pre-proline 0 C--N 1.353 0.733 0 CA-C-N 118.974 0.806 . . . . 0.0 112.64 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.54 -7.17 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.22 2.613 . . . . 0.0 110.477 -170.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -69.82 -46.68 65.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.03 -31.04 23.66 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -54.47 -47.27 73.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.788 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.28 -20.29 62.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.801 0.728 . . . . 0.0 112.465 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -76.6 -35.38 58.13 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.092 0.405 . . . . 0.0 110.142 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.45 -37.81 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -66.93 -35.88 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 123.716 0.806 . . . . 0.0 109.101 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.11 -39.74 90.18 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.85 -32.73 73.46 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.049 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.21 -13.48 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 C-N-CA 123.708 0.803 . . . . 0.0 109.465 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -80.01 -30.65 39.64 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.919 -1.113 . . . . 0.0 108.436 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.25 -36.96 12.94 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 122.009 0.909 . . . . 0.0 110.209 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.97 84.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.437 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.5 tp -70.7 -38.08 73.64 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 71.0 51.51 0.29 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.95 -7.38 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-O 117.267 -1.349 . . . . 0.0 110.151 173.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 66.0 m95 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 60' ' ' ILE 0.256 0.0 OUTLIER -148.49 44.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.068 0 CA-C-O 122.933 1.349 . . . . 0.0 111.89 173.488 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.32 -19.46 14.45 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 150.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.411 HH12 HH11 ' A' ' 99' ' ' ARG . 12.4 ptp180 -84.2 -39.67 19.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -73.43 -31.4 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 119.474 1.033 . . . . 0.0 108.724 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -61.58 -44.42 97.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.45 -16.47 51.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.608 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.92 14.9 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 118.439 0.563 . . . . 0.0 109.701 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.31 -0.73 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.158 -162.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -71.97 -13.13 61.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.476 0.71 . . . . 0.0 110.704 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.23 -35.71 76.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.705 0.802 . . . . 0.0 109.973 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -79.77 -54.06 6.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.54 -12.09 2.96 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 152.62 38.21 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -124.81 13.88 8.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.432 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 60' ' ' ILE . 20.3 t80 96.16 -39.51 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.213 2.605 . . . . 0.0 106.358 -174.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.9 m -81.55 -33.23 31.84 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 117.824 0.284 . . . . 0.0 110.881 -165.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 p -87.35 -21.83 25.45 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.09 -43.91 90.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -42.03 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.842 2.457 . . . . 0.0 111.072 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.76 -45.04 65.5 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 110.547 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.98 83.99 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.087 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.259 24.6 mt -65.98 -28.7 69.08 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 118.723 1.262 . . . . 0.0 112.003 168.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.35 -30.48 57.64 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.92 -36.77 83.01 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.05 -68.35 0.49 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.071 0.548 . . . . 0.0 110.222 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.73 35.87 0.88 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 44.8 mt -106.1 -65.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 102.925 -2.991 . . . . 0.0 102.925 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 49.1 mt-10 52.43 52.54 13.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 126.139 1.775 . . . . 0.0 110.871 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 tp -128.12 -24.67 3.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.95 -162.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.333 0.0 OUTLIER -74.54 143.6 44.43 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 171.81 -38.26 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.092 1 N-CA-C 99.219 -4.363 . . . . 0.0 99.219 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.9 mttt 169.08 131.92 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.764 1 N-CA-C 97.186 -5.116 . . . . 0.0 97.186 -167.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 70.18 78.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-O 123.932 1.825 . . . . 0.0 109.226 168.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' H ' ' H ' ' A' ' 95' ' ' ASP 0.292 0.0 OUTLIER 169.54 -34.07 0.0 OUTLIER 'General case' 0 CA--C 1.454 -2.731 1 N-CA-C 96.359 -5.423 . . . . 0.0 96.359 172.085 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.356 . . -35.97 -41.19 0.23 Allowed 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.677 152.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 93' ' ' LEU . 3.2 p-10 -56.01 -62.55 1.63 Allowed 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -23.54 66.52 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.607 -171.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.39 -29.58 67.82 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.77 0.828 . . . . 0.0 112.103 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 -59.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 HH12 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.49 -25.42 21.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -157.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -123.04 79.94 51.22 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 124.175 0.99 . . . . 0.0 110.828 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -77.21 -5.3 15.62 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.634 2.222 . . . . 0.0 110.503 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -74.02 -50.03 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.87 -32.81 57.76 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -57.38 -39.05 75.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.287 -0.965 . . . . 0.0 113.451 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -69.22 -21.6 63.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 119.161 0.891 . . . . 0.0 112.033 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -73.39 -38.72 65.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 118.521 0.601 . . . . 0.0 110.384 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.14 -46.26 91.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.87 -37.61 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 124.649 1.179 . . . . 0.0 109.396 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -71.97 -31.14 66.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 122.717 0.407 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -70.7 -45.01 65.77 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.81 -28.47 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 C-N-CA 125.076 1.35 . . . . 0.0 110.723 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -39.29 64.38 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 118.279 -1.368 . . . . 0.0 109.052 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -73.75 -48.79 29.21 Favored 'General case' 0 CA--C 1.469 -2.139 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.278 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.74 73.9 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 124.647 1.217 . . . . 0.0 110.363 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.4 tp -103.8 -76.94 0.58 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -64.69 -59.07 4.68 Favored 'General case' 0 CA--C 1.487 -1.463 0 O-C-N 124.925 1.39 . . . . 0.0 111.423 -145.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -83.73 -18.94 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 C--O 1.259 1.596 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.7 m-90 . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.05 -63.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.234 -167.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.57 0.19 46.94 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -29.63 40.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 63' ' ' ILE . 6.1 mt -73.76 -42.02 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 C-N-CA 126.721 2.008 . . . . 0.0 107.933 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.98 -38.6 88.96 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.69 61.78 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.065 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.77 57.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.485 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.3 1.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -163.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -75.45 -13.21 60.37 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 122.341 -0.225 . . . . 0.0 110.636 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.15 68.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -79.63 -45.42 19.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.5 -11.02 4.96 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.47 153.97 35.11 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -122.1 16.5 10.77 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.209 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.327 0.0 OUTLIER 87.07 -21.48 0.19 Allowed 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 126.136 1.774 . . . . 0.0 110.081 176.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.3 m -82.83 -37.62 24.17 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 110.143 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -85.48 -26.5 26.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -61.32 -42.82 99.3 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -37.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 125.332 1.453 . . . . 0.0 111.158 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.54 -45.97 64.48 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.527 0.68 . . . . 0.0 109.678 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.71 73.06 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.726 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.258 16.2 mt -63.67 -35.48 80.67 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.502 1.151 . . . . 0.0 111.54 171.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.36 -38.52 74.8 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.46 -34.12 77.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 123.695 0.798 . . . . 0.0 109.404 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.64 2.62 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.37 33.72 1.57 Allowed Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.85 -70.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 20.0 tt0 48.69 57.24 6.55 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.619 1.967 . . . . 0.0 110.257 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.9 tp -124.79 -12.22 7.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.553 -162.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -166.92 1.49 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 89.96 -27.51 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 128.165 2.586 . . . . 0.0 106.122 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -178.57 118.67 0.08 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.409 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 79.5 82.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 C-N-CA 126.834 2.054 . . . . 0.0 108.256 159.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER 167.8 -32.92 0.0 OUTLIER 'General case' 0 CA--C 1.455 -2.686 1 N-CA-C 98.547 -4.612 . . . . 0.0 98.547 -178.826 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.297 . . -55.93 -25.97 45.68 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 111.427 -2.624 . . . . 0.0 110.792 164.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.62 -55.59 31.52 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -17.55 64.83 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.245 -176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.39 94.27 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 120.293 -1.504 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.16 -46.37 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.76 -36.86 21.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.618 -161.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -126.04 74.25 71.7 Favored Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 110.603 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.89 -6.3 17.93 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.24 2.626 . . . . 0.0 110.36 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -70.14 -45.5 66.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.7 -26.2 17.89 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -170.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.44 -42.33 74.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.944 164.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.06 -19.05 64.08 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 118.784 0.72 . . . . 0.0 112.66 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -76.72 -37.71 55.57 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 118.523 0.601 . . . . 0.0 109.706 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -66.35 -42.88 91.38 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.31 -38.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 124.85 1.26 . . . . 0.0 109.882 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -63.04 -43.86 97.5 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.442 0.697 . . . . 0.0 109.857 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.31 -32.58 66.67 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.776 0.431 . . . . 0.0 111.325 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.55 -12.04 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 C-N-CA 123.814 0.846 . . . . 0.0 109.247 -175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -26.37 46.5 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -90.08 -38.34 13.63 Favored 'General case' 0 CA--C 1.482 -1.653 0 CA-C-O 121.904 0.859 . . . . 0.0 109.814 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.05 63.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.139 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.34 -38.95 59.88 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 172.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 71.16 50.71 0.29 Allowed 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 p -94.7 -5.17 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 C--O 1.261 1.678 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.863 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 21.3 m95 . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.57 -64.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -162.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.18 -4.26 52.42 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -171.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -24.25 45.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' ALA . 12.7 mt -76.83 -44.82 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 C-N-CA 126.396 1.878 . . . . 0.0 106.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.86 -40.43 92.88 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 124.255 0.972 . . . . 0.0 108.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.61 -29.2 64.4 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.0 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.19 -35.99 35.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.935 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.02 -0.59 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 -165.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -77.19 -10.19 59.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 122.141 -0.349 . . . . 0.0 111.757 -172.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.19 -32.89 71.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.11 -47.51 13.41 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.2 -11.07 3.85 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 106.363 -2.695 . . . . 0.0 106.363 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.34 150.57 40.05 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -126.46 23.14 6.93 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.981 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 83.43 -25.57 0.14 Allowed 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.696 1.599 . . . . 0.0 109.833 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -83.74 -39.42 20.12 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 123.124 0.569 . . . . 0.0 109.791 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -89.16 -19.3 25.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -64.86 -43.69 92.17 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.48 -39.87 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.469 1.507 . . . . 0.0 109.973 -174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.24 -45.23 14.09 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.525 0.679 . . . . 0.0 111.19 -171.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.6 -19.05 76.15 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.748 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.02 -40.99 97.56 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 117.443 0.621 . . . . 0.0 110.589 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -72.44 -28.99 63.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -65.71 -37.76 87.34 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.44 -54.79 14.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.38 29.2 1.22 Allowed Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.67 -55.97 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 56.55 43.83 25.09 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.294 1.837 . . . . 0.0 110.431 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.62 125.53 36.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU 0.285 6.2 p-10 174.33 2.57 0.0 OUTLIER 'General case' 0 CA--C 1.451 -2.841 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.74 39.34 1.13 Allowed 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 117.154 -1.818 . . . . 0.0 107.267 -160.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 89' ' ' ASP 0.252 95.7 mttt 112.57 131.89 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.476 1 C-N-CA 132.792 4.437 . . . . 0.0 103.494 175.227 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.251 0.9 OUTLIER 86.88 12.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 126.389 1.876 . . . . 0.0 110.122 155.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 89' ' ' ASP 0.3 0.0 OUTLIER -104.99 -27.3 11.75 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 162.445 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 63' ' ' ILE 0.258 . . -47.98 -28.59 2.84 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 128.294 2.638 . . . . 0.0 111.371 168.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -54.75 43.27 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 124.06 0.85 . . . . 0.0 109.059 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -26.45 65.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.566 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.21 -28.69 68.19 Favored 'General case' 0 N--CA 1.433 -1.293 0 O-C-N 121.731 -0.606 . . . . 0.0 112.3 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.67 -44.48 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -23.02 16.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.719 -156.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -125.26 78.78 66.96 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 123.872 0.869 . . . . 0.0 108.968 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -77.15 -6.99 17.0 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.241 2.627 . . . . 0.0 110.453 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -74.66 -50.16 18.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.84 65.12 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -51.97 -45.59 64.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 170.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -66.21 -30.14 70.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 118.41 0.55 . . . . 0.0 111.446 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -71.91 -39.11 69.74 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.137 -0.352 . . . . 0.0 111.27 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.01 -38.94 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.27 -39.07 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 C-N-CA 124.431 1.092 . . . . 0.0 109.6 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -71.44 -30.54 66.16 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.024 0.53 . . . . 0.0 110.012 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -72.86 -42.23 63.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.16 -30.23 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 125.426 1.49 . . . . 0.0 110.808 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -74.84 -38.66 61.96 Favored 'General case' 0 CA--C 1.48 -1.75 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.18 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.09 -50.11 30.9 Favored 'General case' 0 CA--C 1.476 -1.883 0 C-N-CA 119.066 -1.054 . . . . 0.0 108.821 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -39.46 75.3 Favored 'General case' 0 CA--C 1.483 -1.611 0 O-C-N 124.437 1.086 . . . . 0.0 110.367 -170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.76 -75.85 0.6 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -70.47 -35.37 73.26 Favored 'General case' 0 CA--C 1.486 -1.485 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.76 -144.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.61 -21.55 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -167.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 C--O 1.262 1.742 0 C-N-CA 116.218 -2.193 . . . . 0.0 107.679 172.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' HD13 ' A' ' 60' ' ' ILE . 8.0 m95 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.5 -60.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 O-C-N 121.835 -0.54 . . . . 0.0 109.692 -171.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.01 -1.53 58.15 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -76.88 -38.9 52.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.66 -43.65 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 C-N-CA 125.89 1.676 . . . . 0.0 109.055 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -57.41 -41.07 79.66 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.506 0.67 . . . . 0.0 109.991 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 -21.96 55.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.737 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.88 24.05 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.648 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 35.5 m -92.49 -2.77 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -164.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -86.88 31.71 0.69 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.113 0.482 . . . . 0.0 110.998 -173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.08 -35.16 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.56 -52.48 8.42 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.584 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.83 -12.81 3.39 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 89.4 mt -71.31 148.5 47.03 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -125.24 20.97 8.08 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.554 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.304 0.3 OUTLIER 82.12 -22.2 0.27 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.566 1.546 . . . . 0.0 110.266 177.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -82.05 -38.95 24.17 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.092 0.557 . . . . 0.0 110.229 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -84.16 -21.7 31.25 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -67.35 -44.54 78.81 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -39.93 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 125.935 1.694 . . . . 0.0 109.244 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -47.6 15.59 Favored 'General case' 0 CA--C 1.48 -1.736 0 CA-C-O 121.059 0.456 . . . . 0.0 111.45 -171.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 -17.64 79.76 Favored Glycine 0 CA--C 1.497 -1.064 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.884 -170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.15 -33.83 76.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 117.892 0.846 . . . . 0.0 111.103 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -75.42 -29.69 59.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.55 -35.19 79.63 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.94 -54.19 8.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.01 32.06 1.47 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.4 mt -98.09 -71.48 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 44.09 60.76 2.62 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.514 1.926 . . . . 0.0 109.528 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.78 -8.28 6.72 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.87 -177.09 1.5 Allowed 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 124.344 1.058 . . . . 0.0 110.107 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 107.89 -26.77 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 C-N-CA 129.734 3.213 . . . . 0.0 102.803 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt 177.52 132.07 0.06 Allowed 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 85.53 14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.81 0 C-N-CA 126.01 1.724 . . . . 0.0 109.503 155.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -113.28 -28.72 7.5 Favored 'General case' 0 CA--C 1.457 -2.629 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 160.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.292 . . -42.0 -32.59 0.46 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 129.673 3.189 . . . . 0.0 110.865 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.87 -52.53 63.75 Favored 'General case' 0 N--CA 1.416 -2.136 0 O-C-N 124.055 0.847 . . . . 0.0 109.584 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -28.29 66.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.36 68.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 121.633 -0.667 . . . . 0.0 112.418 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.29 -51.98 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -83.62 -30.9 26.55 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 124.197 0.999 . . . . 0.0 112.466 -162.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.47 79.57 61.35 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 123.486 0.714 . . . . 0.0 109.235 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -77.49 -7.71 16.94 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 123.041 2.494 . . . . 0.0 109.803 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -76.09 -45.38 34.28 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.1 -37.98 53.21 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -53.18 -42.31 66.1 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.96 -37.46 86.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 118.417 0.553 . . . . 0.0 110.016 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -69.0 -35.44 76.69 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 122.419 0.288 . . . . 0.0 111.712 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.65 -41.43 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -42.92 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 123.95 0.9 . . . . 0.0 109.395 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.18 -38.56 91.49 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 122.869 0.468 . . . . 0.0 109.776 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.6 -32.08 70.59 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.444 0.697 . . . . 0.0 110.113 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -85.45 -22.28 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.646 0 C-N-CA 124.262 1.025 . . . . 0.0 110.241 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -8.99 57.85 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.281 35.8 tt0 -103.13 -29.47 11.31 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.18 0.99 . . . . 0.0 108.506 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.91 -31.84 34.97 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.402 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -77.62 -39.47 45.19 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 67.51 49.74 0.98 Allowed 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.427 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.3 p -91.27 -7.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 166.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.261 1.691 0 CA-C-O 117.245 -1.36 . . . . 0.0 110.839 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.767 ' CE2' ' HB3' ' A' ' 93' ' ' LEU 0.256 3.5 t90 . . . . . 0 CA--C 1.5 -0.972 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.52 -58.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.228 0 CA-C-N 114.281 -1.327 . . . . 0.0 114.387 168.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.3 -31.77 8.06 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -78.88 -17.12 56.11 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.632 HD11 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -79.94 -31.45 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 C-N-CA 123.615 0.766 . . . . 0.0 109.058 174.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -12.87 59.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.62 -14.2 18.26 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.97 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.31 -29.66 15.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 m -82.98 -22.82 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -75.6 97.15 3.69 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.91 -49.61 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -83.76 -44.26 14.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.807 -171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.37 -11.0 5.01 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 104.959 -3.256 . . . . 0.0 104.959 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.95 139.03 46.49 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -124.14 19.93 9.06 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.885 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 t80 84.76 -26.63 0.1 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.638 1.975 . . . . 0.0 109.74 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 p -80.19 -28.96 38.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 119.238 0.926 . . . . 0.0 110.396 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -90.46 -27.58 19.15 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -174.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -60.07 -47.64 85.05 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -41.22 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 125.744 1.618 . . . . 0.0 109.608 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 76' ' ' THR . 2.0 p30 -71.54 -51.21 24.71 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-O 121.191 0.519 . . . . 0.0 111.407 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.31 -22.57 77.41 Favored Glycine 0 CA--C 1.494 -1.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.364 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -34.69 78.49 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.975 0.887 . . . . 0.0 111.049 171.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -78.35 -24.19 46.58 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -69.19 -33.94 74.13 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.45 -52.29 23.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.76 29.05 1.61 Allowed Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.08 119.0 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.96 121.1 26.08 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' ' CZ2' ' A' ' 59' ' ' TRP . 2.9 tp -124.13 -166.7 1.53 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -168.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.617 ' HA ' ' CD2' ' A' ' 59' ' ' TRP . 1.9 p30 48.99 164.56 0.0 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 131.344 3.858 . . . . 0.0 118.474 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 95.44 66.76 0.0 OUTLIER 'General case' 0 C--N 1.359 0.987 1 C-N-CA 134.472 5.109 . . . . 0.0 117.694 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.58 ' H ' ' HB3' ' A' ' 59' ' ' TRP 0.546 0.0 OUTLIER 43.73 73.61 0.14 Allowed 'General case' 0 CA--C 1.466 -2.266 1 C-N-CA 137.784 6.434 . . . . 0.0 119.609 175.765 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mt -149.6 -48.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.637 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.767 ' HB3' ' CE2' ' A' ' 59' ' ' TRP 0.399 0.1 OUTLIER -104.66 -24.03 13.01 Favored 'General case' 0 CA--C 1.426 -3.806 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 -158.427 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . . . -82.96 27.63 0.54 Allowed 'General case' 0 N--CA 1.414 -2.254 0 O-C-N 124.588 1.18 . . . . 0.0 110.095 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . 0.276 0.0 OUTLIER -80.8 -54.28 5.74 Favored 'General case' 0 N--CA 1.411 -2.422 1 N-CA-C 99.525 -4.25 . . . . 0.0 99.525 151.704 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -28.37 66.12 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.173 -173.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' A' ' 94' ' ' ALA . . . -59.35 -33.43 71.15 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 120.969 -1.082 . . . . 0.0 112.227 -174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.58 -48.88 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.63 -15.97 16.87 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.326 -158.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -125.4 75.38 68.92 Favored Pre-proline 0 C--N 1.358 0.943 0 C-N-CA 123.485 0.714 . . . . 0.0 109.832 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.16 -3.21 13.47 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.164 2.576 . . . . 0.0 110.561 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -75.96 -45.7 33.54 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.47 -34.91 41.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.67 -39.26 67.91 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 118.511 -1.275 . . . . 0.0 113.794 167.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.49 -13.7 61.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 118.493 0.588 . . . . 0.0 112.209 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -80.86 -33.43 34.45 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 118.778 0.717 . . . . 0.0 110.029 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.28 -36.92 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.17 -30.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -70.74 -24.0 62.54 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -71.88 -52.39 17.57 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.55 33.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 125.882 1.673 . . . . 0.0 110.682 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 -33.91 11.15 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 120.938 -1.101 . . . . 0.0 108.1 149.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.11 -43.08 11.31 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.876 0.846 . . . . 0.0 109.891 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.07 -20.93 60.13 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -71.6 -81.53 0.05 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.89 -14.03 14.03 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -153.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.4 t 67.59 37.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -167.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.26 1.627 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 90' ' ' ARG . 15.2 p90 . . . . . 0 CA--C 1.458 -2.57 0 N-CA-C 101.21 -3.626 . . . . 0.0 101.21 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.311 0.1 OUTLIER -131.07 -64.99 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 O-C-N 125.062 1.476 . . . . 0.0 114.365 -159.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.06 25.1 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 2.7 ptp180 -70.26 -31.5 68.9 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 124.962 1.305 . . . . 0.0 109.987 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.85 -28.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -76.26 -25.5 55.02 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.63 -20.63 49.89 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.447 -164.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.26 -27.39 13.81 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 34.1 m -86.59 -16.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.36 -16.58 62.99 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.877 0.871 . . . . 0.0 112.201 -171.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -39.59 80.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -79.49 -39.71 31.46 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.54 -5.75 6.24 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 106.059 -2.816 . . . . 0.0 106.059 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 95.7 mt -74.91 142.03 44.07 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -121.68 21.18 10.89 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.569 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 84.66 -26.69 0.11 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.312 1.845 . . . . 0.0 109.159 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.0 t -82.36 -41.6 19.78 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 118.831 0.741 . . . . 0.0 111.119 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -85.87 -24.78 26.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -58.98 -49.14 79.02 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -39.57 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.611 1.965 . . . . 0.0 109.895 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.03 -45.84 25.81 Favored 'General case' 0 CA--C 1.474 -1.977 0 CA-C-O 121.716 0.769 . . . . 0.0 109.671 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.49 -13.91 68.75 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.931 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 7.5 mp -58.61 -47.49 84.16 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 118.168 0.984 . . . . 0.0 110.38 169.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -70.05 -33.77 72.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -64.56 -38.67 91.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 123.363 0.665 . . . . 0.0 109.878 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.49 -57.66 3.7 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 122.399 0.28 . . . . 0.0 110.342 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.91 32.25 1.03 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.7 mm -88.79 -72.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.98 32.15 19.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 125.79 1.636 . . . . 0.0 110.201 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.67 133.79 49.62 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -167.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -149.46 -51.22 0.15 Allowed 'General case' 0 CA--C 1.481 -1.68 0 CA-C-N 118.717 0.69 . . . . 0.0 110.783 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' CG ' ' A' ' 59' ' ' TRP . 34.5 ttt85 -74.84 70.11 1.9 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -145.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 94' ' ' ALA 0.285 65.6 mttt 61.95 42.95 9.6 Favored 'General case' 0 CA--C 1.474 -1.974 0 C-N-CA 129.402 3.081 . . . . 0.0 106.338 -176.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 mm -139.2 -13.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-N 109.271 -3.604 . . . . 0.0 105.328 -165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.7 -36.99 0.08 Allowed 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.261 . . -55.32 -30.42 60.21 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.723 159.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -52.86 62.83 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -19.89 66.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.595 0.758 . . . . 0.0 110.28 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.15 90.02 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 120.414 -1.429 . . . . 0.0 110.334 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.54 -46.78 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -84.44 -40.42 17.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.998 0.919 . . . . 0.0 111.197 -162.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -126.28 74.25 72.94 Favored Pre-proline 0 N--CA 1.442 -0.841 0 C-N-CA 123.562 0.745 . . . . 0.0 110.635 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -77.58 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.571 2.181 . . . . 0.0 110.156 -168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.15 -41.15 42.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.07 47.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -56.75 -39.13 73.45 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.253 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.35 -31.0 71.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 118.174 0.443 . . . . 0.0 110.478 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -71.12 -38.58 72.32 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.28 -42.57 94.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.7 -39.35 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 C-N-CA 124.859 1.263 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.71 -43.82 92.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.89 -39.2 87.4 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 122.353 0.261 . . . . 0.0 111.484 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.3 -9.28 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.628 0 C-N-CA 125.0 1.32 . . . . 0.0 109.671 -172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -77.95 -35.0 50.83 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.268 51.3 mt-10 -89.29 -17.71 28.41 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.028 0.918 . . . . 0.0 111.706 -172.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.14 -17.34 20.93 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp -80.72 -27.29 36.96 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 170.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 65.66 39.48 4.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.269 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.95 -3.51 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.176 171.015 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.6 m-90 . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -161.39 -62.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -168.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.85 -4.08 37.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -19.0 44.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 173.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mt -79.47 -43.21 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.67 -36.55 81.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.93 67.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.372 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.09 -36.37 48.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.492 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 33.5 m -92.98 0.53 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -164.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -77.89 -12.49 59.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 122.323 -0.236 . . . . 0.0 110.51 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.87 70.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.35 -44.31 25.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.28 -5.75 5.98 Favored Glycine 0 CA--C 1.489 -1.563 0 N-CA-C 106.425 -2.67 . . . . 0.0 106.425 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 76.6 mt -76.78 154.13 34.29 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.48 27.8 6.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.061 -175.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 81.15 -29.44 0.12 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 126.256 1.823 . . . . 0.0 109.797 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.3 m -80.19 -39.68 28.71 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.275 0.63 . . . . 0.0 110.327 -168.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -26.41 26.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -175.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.46 -44.5 95.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.94 88.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 126.926 2.09 . . . . 0.0 109.661 -175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.9 -49.64 77.03 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 174.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.04 -23.58 76.04 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 119.285 -0.73 . . . . 0.0 113.038 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.698 HD13 ' H ' ' A' ' 88' ' ' LEU 0.291 2.5 mt -66.05 -36.11 82.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 118.963 1.382 . . . . 0.0 111.111 172.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -77.05 -27.93 54.6 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -68.78 -36.4 78.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.61 -48.83 36.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.02 28.17 2.74 Favored Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.0 mt -98.91 -57.89 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 -174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 58.22 80.01 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 125.535 1.534 . . . . 0.0 108.671 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -121.05 -153.33 0.54 Allowed 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -171.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.769 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER 25.25 90.88 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 128.523 2.729 . . . . 0.0 113.725 -176.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.76 -26.24 1.07 Allowed 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 162.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt 171.78 132.48 0.02 OUTLIER 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.278 0.8 OUTLIER 85.22 24.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 127.547 2.339 . . . . 0.0 106.885 158.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 ' HB3' ' A' ' 89' ' ' ASP 0.306 0.0 OUTLIER -112.49 -29.52 7.46 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 153.743 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . . . -55.78 -23.95 32.87 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 129.673 3.189 . . . . 0.0 111.392 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HA ' HH11 ' A' ' 99' ' ' ARG . 7.3 p-10 -63.79 -49.9 71.12 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -20.26 62.33 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.199 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.56 91.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.41 -43.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 95' ' ' ASP . 3.7 mpt_? -90.32 -28.09 18.97 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.552 -161.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -125.79 74.48 70.54 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 118.785 0.72 . . . . 0.0 110.01 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.11 -4.17 14.54 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.267 2.644 . . . . 0.0 110.246 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.63 -47.6 53.44 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.39 -30.16 19.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -56.27 -43.71 79.05 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.119 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.65 -11.48 60.43 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 118.618 0.645 . . . . 0.0 112.607 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.07 -37.31 39.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 118.716 0.689 . . . . 0.0 109.421 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.85 -39.3 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.36 -35.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 124.349 1.06 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.46 -26.56 62.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 122.635 0.374 . . . . 0.0 110.323 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -75.72 -40.51 55.47 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.571 -0.705 . . . . 0.0 109.582 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.66 -6.12 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 124.525 1.13 . . . . 0.0 111.577 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -25.04 55.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 O-C-N 119.974 -1.704 . . . . 0.0 108.767 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -88.84 -41.27 12.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 124.462 1.105 . . . . 0.0 110.209 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.61 76.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.08 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -73.19 -39.28 65.72 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 70.6 49.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.183 -1.371 . . . . 0.0 107.363 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.65 -9.0 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 164.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 . . . . . 0 C--O 1.261 1.673 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.023 173.559 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 4.2 m95 . . . . . 0 CA--C 1.5 -0.96 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.51 -62.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -165.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.52 -6.2 52.89 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -19.86 48.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mt -81.81 -43.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 C-N-CA 126.509 1.923 . . . . 0.0 106.115 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -63.25 -42.11 99.14 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.36 -25.69 63.39 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.552 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.51 -42.49 43.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.563 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.28 -1.0 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.483 -161.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -76.32 -10.42 59.39 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 122.471 0.308 . . . . 0.0 110.869 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.99 -37.96 82.11 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -79.03 -45.44 20.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.57 -6.86 5.26 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.08 146.92 41.07 Favored 'General case' 0 CA--C 1.471 -2.066 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -127.72 39.18 3.91 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.639 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.6 t80 79.44 -28.81 0.14 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.426 1.49 . . . . 0.0 111.012 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -84.37 -38.29 20.48 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 119.129 0.877 . . . . 0.0 111.966 -172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -25.09 19.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -59.78 -45.73 91.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 169.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -40.41 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.478 1.511 . . . . 0.0 109.748 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -80.69 -44.44 18.74 Favored 'General case' 0 CA--C 1.477 -1.859 0 CA-C-O 121.595 0.712 . . . . 0.0 110.567 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.05 -17.26 73.56 Favored Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.832 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.31 -36.16 82.76 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 117.954 0.877 . . . . 0.0 112.094 168.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.59 -29.03 56.39 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.51 -32.46 73.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.61 -55.33 5.77 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.04 32.74 1.79 Allowed Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.08 65.68 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -85.8 84.28 7.6 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -130.3 -13.66 3.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.242 -157.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' LYS 0.25 9.1 p-10 -77.09 5.02 8.91 Favored 'General case' 0 CA--C 1.459 -2.541 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -87.85 24.28 1.81 Allowed 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 117.152 -1.819 . . . . 0.0 108.3 -169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 89' ' ' ASP . 89.4 mttt 126.65 126.21 0.0 OUTLIER 'General case' 0 N--CA 1.41 -2.437 2 C-N-CA 134.028 4.931 . . . . 0.0 100.153 178.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 81.18 82.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 C-N-CA 125.676 1.591 . . . . 0.0 109.358 164.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 89' ' ' ASP 0.287 0.0 OUTLIER 179.08 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.356 1 N-CA-C 97.923 -4.843 . . . . 0.0 97.923 177.781 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.269 . . -46.76 -37.12 8.06 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 111.496 -2.593 . . . . 0.0 109.777 158.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -55.82 -60.03 4.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -24.63 67.4 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.396 -171.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.94 -33.9 76.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.418 -0.801 . . . . 0.0 111.586 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.92 -66.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.97 -27.31 26.57 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -159.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -123.88 80.7 56.48 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 118.857 0.753 . . . . 0.0 111.685 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.28 -4.72 14.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.141 1.894 . . . . 0.0 110.465 -171.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -77.18 -44.27 30.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.84 -36.55 59.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -55.84 -41.17 73.89 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -64.59 -31.62 72.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 117.871 0.305 . . . . 0.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -72.57 -37.63 68.15 Favored 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 122.782 0.433 . . . . 0.0 111.797 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.44 -41.7 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 t -64.97 -36.26 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 124.633 1.173 . . . . 0.0 109.654 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -72.42 -30.95 65.08 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 122.959 0.503 . . . . 0.0 110.406 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -75.91 -34.44 59.93 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.53 -15.94 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 pptp? -78.83 -29.4 44.68 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.674 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.6 -37.05 14.95 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.96 0.886 . . . . 0.0 111.006 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.76 -35.49 72.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.66 -39.61 70.19 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 69.86 52.26 0.41 Allowed 'General case' 0 N--CA 1.433 -1.292 0 O-C-N 125.11 1.506 . . . . 0.0 107.115 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.93 -9.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 164.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.262 1.716 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.764 176.091 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.839 ' CD2' ' HA ' ' A' ' 89' ' ' ASP . 1.8 t90 . . . . . 0 CA--C 1.485 -1.527 1 N-CA-C 96.947 -5.205 . . . . 0.0 96.947 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -138.26 -69.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.365 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.218 175.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 -26.88 12.78 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.251 11.5 mtp180 -61.98 -39.76 93.3 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.811 169.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.47 HG13 ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.4 -22.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.052 -164.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -23.68 64.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.48 -5.7 21.35 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.76 -40.32 9.42 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.2 m -91.94 2.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.598 -164.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -72.01 -14.51 61.9 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.107 0.963 . . . . 0.0 111.509 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.46 71.67 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -76.58 -47.18 23.29 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.62 -10.34 4.01 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 106.083 -2.807 . . . . 0.0 106.083 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.35 153.83 39.13 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -125.74 15.71 8.09 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.339 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 24.7 t80 83.08 -19.04 0.42 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 126.609 1.964 . . . . 0.0 109.503 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -80.16 -32.18 38.86 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 121.498 -0.751 . . . . 0.0 109.507 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.21 -32.95 24.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.95 -47.75 81.99 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -40.13 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.207 0 C-N-CA 126.056 1.743 . . . . 0.0 109.839 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.77 -43.02 80.79 Favored 'General case' 0 CA--C 1.464 -2.345 0 CA-C-O 121.38 0.61 . . . . 0.0 110.019 -171.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.49 68.97 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.098 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mt -67.64 -36.69 81.26 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-N 118.754 1.277 . . . . 0.0 110.43 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.55 -17.94 52.86 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -76.11 -33.52 59.48 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.83 -39.39 64.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.79 38.13 4.76 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -126.1 128.25 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.48 109.38 20.67 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.4 tp -127.55 92.16 3.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -168.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.839 ' HA ' ' CD2' ' A' ' 59' ' ' TRP . 8.6 p-10 161.99 131.51 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.782 0 C-N-CA 125.771 1.628 . . . . 0.0 111.928 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 179.38 80.52 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.247 -2.872 . . . . 0.0 103.247 111.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.687 ' H ' ' HB2' ' A' ' 59' ' ' TRP 0.317 16.8 ttmt 76.11 61.35 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 126.681 1.992 . . . . 0.0 114.617 163.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.489 ' HB ' ' CZ3' ' A' ' 59' ' ' TRP . 8.3 mt -152.63 -33.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.395 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.779 ' HB3' ' CD2' ' A' ' 59' ' ' TRP 0.352 0.1 OUTLIER -110.37 -27.39 9.07 Favored 'General case' 0 CA--C 1.464 -2.332 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -175.509 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 63' ' ' ILE 0.427 . . -25.98 -47.12 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.744 1 C-N-CA 132.119 4.168 . . . . 0.0 113.977 153.444 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.66 -46.85 16.39 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -10.95 34.53 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.015 1.447 . . . . 0.0 112.266 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.52 68.7 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.417 -1.427 . . . . 0.0 108.611 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.57 -53.57 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -91.64 -31.0 16.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -123.79 69.33 45.72 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 123.684 0.794 . . . . 0.0 110.667 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.01 0.72 9.6 Favored 'Trans proline' 0 N--CA 1.439 -1.676 0 C-N-CA 123.884 3.056 . . . . 0.0 109.943 -171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -76.14 -41.82 48.78 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.18 18.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 93' ' ' LEU . 21.9 t80 -55.28 -40.28 70.85 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 117.374 -1.73 . . . . 0.0 113.658 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.65 -25.01 65.51 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 119.158 0.89 . . . . 0.0 112.123 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -71.22 -36.69 71.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 118.721 0.691 . . . . 0.0 110.688 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.32 -40.98 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.259 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.2 t -61.65 -43.22 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 124.185 0.994 . . . . 0.0 109.673 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.21 -36.9 84.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -71.51 -31.08 66.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.544 0.738 . . . . 0.0 110.916 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.12 -21.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.031 0 C-N-CA 124.34 1.056 . . . . 0.0 110.202 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -87.82 -6.21 58.23 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -99.58 -27.28 13.77 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.74 -25.9 37.73 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -84.95 -34.39 22.46 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 64.18 51.04 2.26 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.878 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.5 -11.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.261 1.684 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.327 -176.563 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.505 ' HA ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.939 1.352 . . . . 0.0 107.97 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.298 0.6 OUTLIER -141.56 -77.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 117.34 -1.744 . . . . 0.0 113.729 171.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.81 -34.82 45.04 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.7 ptp180 -72.08 -27.93 62.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.688 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -90.76 -17.42 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 122.569 0.348 . . . . 0.0 111.464 -170.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.27 -22.13 24.09 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.32 -19.14 31.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.072 -168.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.47 -30.82 16.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.02 -13.5 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -165.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -74.39 -11.93 60.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.099 0.56 . . . . 0.0 111.885 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.67 70.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -77.41 -42.0 37.84 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.386 -169.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.24 -10.22 5.06 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.37 142.77 47.0 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -120.11 22.7 11.32 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.439 -171.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.6 t80 83.1 -28.96 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.515 1.926 . . . . 0.0 110.131 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.4 m -79.21 -40.75 29.94 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 118.399 0.545 . . . . 0.0 109.833 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 p -85.21 -23.3 28.34 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -62.6 -44.98 94.95 Favored 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.17 -41.73 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 O-C-N 124.978 1.424 . . . . 0.0 109.935 -174.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -68.08 -44.21 76.8 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 121.877 0.846 . . . . 0.0 110.64 -174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.66 -22.87 75.48 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.023 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.71 -41.31 98.12 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 118.371 1.086 . . . . 0.0 111.524 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -75.86 -29.58 58.59 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -69.23 -36.51 77.29 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.92 71.19 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.33 29.71 7.75 Favored Glycine 0 CA--C 1.484 -1.903 0 N-CA-C 106.161 -2.776 . . . . 0.0 106.161 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.85 81.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.956 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 80.21 8.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.6 tp -127.95 104.75 7.97 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -163.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.3 165.05 4.0 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 94.7 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.268 2.627 . . . . 0.0 108.189 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 68.76 64.55 0.31 Allowed 'General case' 0 CA--C 1.476 -1.892 0 C-N-CA 128.205 2.602 . . . . 0.0 106.848 176.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mm -158.7 -47.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 -159.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 63' ' ' ILE 0.257 0.0 OUTLIER -114.93 -31.68 6.01 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -175.108 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.281 . . -59.16 -29.58 67.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.467 164.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -52.1 57.64 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 101.394 -3.558 . . . . 0.0 101.394 176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -20.15 66.24 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.828 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.72 93.7 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.284 -1.51 . . . . 0.0 110.628 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.32 -44.43 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -89.1 -35.94 16.02 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.504 -161.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -126.35 72.77 72.63 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -76.55 -9.67 18.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.721 2.281 . . . . 0.0 109.913 -167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -72.01 -44.16 63.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.0 -35.1 57.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -52.42 -45.98 66.15 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.23 -14.89 61.9 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -82.43 -34.29 28.26 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 118.461 0.573 . . . . 0.0 110.112 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.45 -32.94 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.26 -37.05 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -67.14 -26.05 66.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 122.12 -0.363 . . . . 0.0 110.051 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -75.1 -50.69 15.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 121.799 -0.563 . . . . 0.0 109.767 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 111' ' ' VAL . 44.9 t -88.64 19.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 126.167 1.787 . . . . 0.0 110.7 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -45.18 15.21 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 161.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -94.97 -31.27 13.71 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-O 123.057 1.408 . . . . 0.0 110.226 -171.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -71.62 -20.81 61.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.75 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.78 -63.05 1.14 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 160.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -157.86 -69.64 0.09 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.436 ' H ' ' H ' ' A' ' 118' ' ' GLN . 7.3 p -162.33 -26.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.436 ' H ' ' H ' ' A' ' 117' ' ' VAL . 15.6 pt20 . . . . . 0 C--O 1.26 1.628 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.855 -165.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.464 ' N ' HD13 ' A' ' 60' ' ' ILE . 15.0 m-90 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.265 0.555 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -147.47 -57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.502 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -172.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.31 -4.43 51.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -79.6 -33.18 41.79 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 124.745 1.218 . . . . 0.0 108.293 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -78.51 -41.48 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.463 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -62.53 -29.58 70.67 Favored 'General case' 0 CA--C 1.495 -1.168 0 O-C-N 123.782 0.676 . . . . 0.0 110.303 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 -21.9 35.7 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.996 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.58 31.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.129 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.41 -16.6 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.56 92.31 5.29 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.57 -47.98 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -171.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -84.32 -45.52 12.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.684 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.93 -11.5 4.5 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.8 mt -73.0 143.21 47.66 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.66 9.18 9.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.579 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 92.36 -22.87 0.07 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.144 2.178 . . . . 0.0 107.461 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.3 t -80.61 -43.3 20.76 Favored 'General case' 0 CA--C 1.487 -1.459 0 O-C-N 121.603 -0.685 . . . . 0.0 109.326 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 p -82.29 -24.4 34.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -71.53 -39.45 70.72 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -56.78 -44.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 O-C-N 124.92 1.387 . . . . 0.0 108.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -45.18 69.27 Favored 'General case' 0 CA--C 1.477 -1.845 0 O-C-N 123.551 0.532 . . . . 0.0 111.477 -169.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.81 -27.1 74.14 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.699 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 78' ' ' ILE . 6.7 mt -62.74 -43.28 99.22 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 117.875 0.837 . . . . 0.0 109.357 172.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -81.76 -15.4 54.41 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -77.19 -32.34 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -49.84 28.72 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.31 31.92 1.32 Allowed Glycine 0 CA--C 1.485 -1.83 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.34 -47.09 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 59.01 65.94 1.13 Allowed 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 125.118 1.367 . . . . 0.0 109.097 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.94 -161.26 1.06 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.804 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' HD13 ' A' ' 93' ' ' LEU . 0.7 OUTLIER 44.72 61.96 2.26 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 127.834 2.454 . . . . 0.0 108.433 -172.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -96.43 -45.63 6.7 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? 165.74 137.99 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 86.97 4.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 C-N-CA 127.758 2.423 . . . . 0.0 107.127 162.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 89' ' ' ASP 0.358 0.1 OUTLIER -101.37 -29.45 12.03 Favored 'General case' 0 CA--C 1.438 -3.338 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 163.127 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.35 16.01 Favored 'General case' 0 CA--C 1.471 -2.078 0 C-N-CA 126.939 2.096 . . . . 0.0 111.743 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.52 -55.3 33.48 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -29.39 69.14 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.787 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.51 -31.26 67.72 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 118.569 0.622 . . . . 0.0 112.446 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.51 -62.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.6 -13.84 31.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -159.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -119.44 75.44 17.27 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 110.186 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -79.31 -3.1 12.82 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 122.97 2.447 . . . . 0.0 110.592 -168.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -78.85 -47.25 16.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.24 65.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.39 -42.17 66.67 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.27 -31.4 72.53 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 118.812 0.733 . . . . 0.0 110.548 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -69.45 -38.19 77.68 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.881 -0.512 . . . . 0.0 111.443 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.7 -37.02 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.14 -35.95 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.856 1.263 . . . . 0.0 109.491 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -75.65 -25.53 56.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.461 0.705 . . . . 0.0 109.656 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -74.31 -41.67 60.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.2 -8.31 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 C-N-CA 124.701 1.2 . . . . 0.0 111.64 -171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -30.34 61.24 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.885 -1.526 . . . . 0.0 107.58 173.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.64 -37.73 16.51 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.26 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.65 -22.05 57.11 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.251 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -78.42 -34.14 48.14 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 70.86 42.14 0.8 Allowed 'General case' 0 CA--C 1.492 -1.286 0 O-C-N 124.813 1.32 . . . . 0.0 107.964 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.3 -9.75 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 C--O 1.259 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.356 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.504 ' HB2' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.486 -1.502 0 CA-C-O 122.937 1.351 . . . . 0.0 108.129 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.278 0.5 OUTLIER -149.1 -74.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 C-N-CA 116.261 -2.176 . . . . 0.0 113.02 167.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.97 -33.83 24.52 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.441 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 4.8 ptp180 -71.98 -27.54 62.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.049 0.939 . . . . 0.0 108.896 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -92.2 -19.31 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 122.883 0.473 . . . . 0.0 111.268 -171.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.83 -24.83 30.78 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.95 -20.07 31.18 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.732 -170.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.67 -37.05 23.3 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.64 -13.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -165.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -74.46 -11.02 60.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.54 -32.45 62.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -83.75 -43.82 15.07 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -170.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.78 -9.76 4.56 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 106.226 -2.75 . . . . 0.0 106.226 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.86 142.9 46.04 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -119.55 24.96 10.36 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.743 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 t80 82.16 -26.83 0.13 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.162 1.785 . . . . 0.0 110.417 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 t -83.07 -36.15 25.13 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 p -88.52 -21.04 24.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -63.98 -46.25 85.46 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -39.49 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 125.68 1.592 . . . . 0.0 109.57 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -45.95 53.65 Favored 'General case' 0 CA--C 1.476 -1.9 0 CA-C-O 121.759 0.79 . . . . 0.0 110.025 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.21 -15.39 74.62 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.343 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -63.73 -35.42 80.5 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.849 1.324 . . . . 0.0 111.903 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -72.42 -36.91 68.72 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -67.29 -31.37 71.64 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 123.473 0.709 . . . . 0.0 109.742 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.15 -58.48 3.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.67 35.06 1.45 Allowed Glycine 0 CA--C 1.489 -1.564 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -98.23 -66.91 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 52.5 52.47 14.06 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.266 1.426 . . . . 0.0 110.393 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.08 -127.72 0.27 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -159.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.41 -173.96 0.14 Allowed 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 124.741 1.216 . . . . 0.0 110.192 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 87.11 50.35 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 129.142 2.977 . . . . 0.0 109.368 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER 70.16 65.68 0.22 Allowed 'General case' 0 CA--C 1.475 -1.938 0 C-N-CA 128.827 2.851 . . . . 0.0 106.887 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -159.38 -46.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 -159.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -112.11 -32.78 6.45 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -176.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.318 . . -55.31 -34.27 64.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.01 166.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.62 10.77 Favored 'General case' 0 CA--C 1.471 -2.065 1 N-CA-C 100.193 -4.003 . . . . 0.0 100.193 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -15.15 63.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.349 -169.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.7 91.88 Favored 'General case' 0 CA--C 1.489 -1.379 0 O-C-N 120.221 -1.549 . . . . 0.0 110.406 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.52 -60.94 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -25.63 24.06 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -163.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.22 69.29 50.07 Favored Pre-proline 0 C--N 1.354 0.77 0 CA-C-N 119.076 0.853 . . . . 0.0 112.032 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.98 -5.39 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.237 2.624 . . . . 0.0 110.488 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -76.68 -40.12 49.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.39 -33.29 25.81 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -55.41 -41.11 72.3 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.875 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.27 -28.91 68.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.28 0.491 . . . . 0.0 111.534 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -73.24 -35.67 66.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 O-C-N 121.956 -0.465 . . . . 0.0 110.599 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.43 -38.53 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.58 -43.76 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -61.2 -39.2 89.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 122.483 0.313 . . . . 0.0 110.247 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.86 -33.02 73.11 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.432 0.693 . . . . 0.0 111.36 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.97 -17.86 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 C-N-CA 123.888 0.875 . . . . 0.0 109.863 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -83.67 -14.76 51.06 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.275 32.9 tt0 -100.61 -26.29 13.87 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.24 -34.21 42.91 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.752 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.4 tp -78.87 -36.54 42.06 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 103.46 -2.792 . . . . 0.0 103.46 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 64.4 49.21 2.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.231 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.62 -8.7 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 168.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 C--O 1.259 1.577 0 CA-C-O 117.185 -1.388 . . . . 0.0 111.5 -179.166 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG12 ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -141.03 -86.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -156.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' H ' HG12 ' A' ' 60' ' ' ILE . . . -82.18 -17.43 46.29 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.754 HH21 HG21 ' A' ' 98' ' ' VAL . 1.6 mmp_? -62.22 -40.37 95.9 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 126.272 1.829 . . . . 0.0 109.991 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.5 -41.32 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.65 -27.02 66.0 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 124.127 0.892 . . . . 0.0 111.193 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.16 34.51 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.83 -36.04 20.28 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.26 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.06 -14.32 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -164.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -72.98 -19.28 61.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 122.846 0.459 . . . . 0.0 111.364 -171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.98 62.15 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.43 -46.57 22.21 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.92 -6.74 6.11 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.84 145.67 44.73 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -118.42 10.61 12.75 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 7.8 t80 83.31 -15.01 0.67 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.13 2.172 . . . . 0.0 109.956 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.6 t -81.11 -38.57 27.03 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -80.96 -31.49 34.85 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -63.78 -42.07 97.84 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -41.61 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 125.562 1.545 . . . . 0.0 108.944 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -76.39 -52.85 9.06 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.214 0.531 . . . . 0.0 111.695 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.77 -10.78 83.73 Favored Glycine 0 CA--C 1.496 -1.116 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.317 -164.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 88' ' ' LEU . 3.3 tt -60.02 -43.66 95.12 Favored 'General case' 0 CA--C 1.49 -1.335 0 C-N-CA 124.927 1.291 . . . . 0.0 108.868 168.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.3 -34.27 72.54 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -65.47 -39.88 92.5 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.02 -65.2 0.73 Allowed 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.361 0.665 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 46.9 1.61 Allowed Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 -171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -98.35 171.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.399 -0.9 . . . . 0.0 110.001 -168.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 86' ' ' ILE . 52.1 mt-10 -67.1 121.4 15.51 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.12 141.41 31.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.788 -158.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 93' ' ' LEU . 30.4 m-20 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-O 122.253 1.025 . . . . 0.0 110.441 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 93' ' ' LEU . 88.5 mtm180 -125.77 -168.88 1.91 Allowed 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 166.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -97.97 -4.13 36.92 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . 0.287 5.1 mt -104.28 -12.86 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 131.041 3.736 . . . . 0.0 102.487 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.724 ' HB3' ' H ' ' A' ' 90' ' ' ARG 0.355 0.3 OUTLIER -107.33 -33.65 7.33 Favored 'General case' 0 CA--C 1.433 -3.531 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.881 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -77.79 16.36 0.7 Allowed 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 124.44 1.088 . . . . 0.0 110.766 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.32 -41.29 57.16 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-O 122.392 1.091 . . . . 0.0 108.247 155.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.76 63.53 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.33 72.45 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.665 -1.272 . . . . 0.0 112.038 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG21 HH21 ' A' ' 62' ' ' ARG . 48.4 t -96.02 -55.87 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -174.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.09 -11.74 18.63 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 119.006 -0.521 . . . . 0.0 112.092 -158.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.59 75.31 54.58 Favored Pre-proline 0 C--N 1.359 0.997 0 CA-C-N 119.175 0.898 . . . . 0.0 110.06 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.03 2.5 7.89 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 123.416 2.744 . . . . 0.0 110.457 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.51 -48.86 18.07 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.15 -42.11 47.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.232 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -60.96 -32.23 71.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -75.82 -12.75 60.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 120.404 1.457 . . . . 0.0 111.447 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.18 -32.76 29.78 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.52 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.224 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 t -67.81 -34.19 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 125.159 1.383 . . . . 0.0 109.231 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -69.06 -27.99 66.13 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 122.162 -0.336 . . . . 0.0 111.111 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -79.02 -40.34 31.66 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.793 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 63.2 t -87.1 3.47 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 C-N-CA 123.988 0.915 . . . . 0.0 111.256 -170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -28.39 38.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 119.979 -1.701 . . . . 0.0 107.462 171.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.07 -30.06 13.27 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.815 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -85.4 -7.61 58.85 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.382 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.07 -35.53 20.21 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 164.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.48 HE21 HE21 ' A' ' 118' ' ' GLN . 10.6 tp60 71.48 36.87 1.22 Allowed 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -88.05 -14.08 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.48 HE21 HE21 ' A' ' 116' ' ' GLN . 4.2 pp0? . . . . . 0 C--O 1.261 1.669 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.532 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 . . . . . 0 CA--C 1.484 -1.584 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -160.04 -65.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.142 -168.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.96 9.49 40.47 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -28.52 39.48 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.5 mt -77.88 -44.55 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 126.335 1.854 . . . . 0.0 106.623 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -59.32 -41.33 88.83 Favored 'General case' 0 CA--C 1.485 -1.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.207 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.37 62.35 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.64 -35.43 30.0 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.428 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 30.7 m -92.98 -1.43 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -87.1 28.07 0.96 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 118.172 0.442 . . . . 0.0 110.71 -173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.37 -26.01 11.18 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 173.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -88.86 -50.79 5.99 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -169.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.91 -15.4 3.07 Favored Glycine 0 CA--C 1.49 -1.512 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 -172.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 62.2 mt -72.56 144.52 47.9 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -124.89 23.92 7.75 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.467 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.1 t80 82.54 -31.67 0.09 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.268 1.827 . . . . 0.0 109.959 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -82.07 -32.05 30.53 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 118.197 0.453 . . . . 0.0 110.434 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -87.38 -22.63 24.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.44 -41.39 89.23 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.65 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 126.269 1.828 . . . . 0.0 110.557 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -60.67 2.71 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.79 84.72 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.801 -165.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 87' ' ' GLU . 32.4 mt -65.16 -36.6 84.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 117.952 0.876 . . . . 0.0 111.252 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -69.36 -35.95 76.37 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.97 -32.34 72.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.404 0.681 . . . . 0.0 109.731 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.3 -37.78 43.95 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.842 0.457 . . . . 0.0 110.379 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.54 33.94 3.47 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.44 -71.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 24.5 tt0 46.02 55.35 7.18 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 127.77 2.428 . . . . 0.0 110.058 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -128.72 -30.8 2.26 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.878 -164.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.44 95.96 7.84 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -148.19 -33.36 0.24 Allowed 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 100.403 -3.925 . . . . 0.0 100.403 173.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? 177.16 135.81 0.06 Allowed 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 91.54 -3.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 C-N-CA 128.84 2.856 . . . . 0.0 107.708 156.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.361 0.1 OUTLIER -90.22 -30.59 17.47 Favored 'General case' 0 CA--C 1.425 -3.847 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 163.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.1 -15.15 1.96 Allowed 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 127.699 2.399 . . . . 0.0 112.553 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -53.03 -54.05 41.17 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 124.005 0.815 . . . . 0.0 109.067 163.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG3' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -69.13 -28.75 66.74 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.06 -29.54 68.61 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 121.089 -1.007 . . . . 0.0 112.865 -174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -48.55 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -84.43 -27.36 27.61 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.212 -161.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -125.24 81.49 63.49 Favored Pre-proline 0 C--N 1.358 0.944 0 C-N-CA 123.991 0.916 . . . . 0.0 109.854 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.58 -7.58 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.528 2.152 . . . . 0.0 110.678 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -73.19 -46.82 48.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 96' ' ' MET . . . -82.56 -30.32 29.74 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -53.95 -41.43 67.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 119.111 -1.036 . . . . 0.0 113.182 166.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.64 -21.74 64.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.793 0.724 . . . . 0.0 112.725 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.78 -37.71 64.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 118.874 0.761 . . . . 0.0 110.333 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.6 t -65.94 -42.81 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.63 -31.81 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 124.616 1.166 . . . . 0.0 109.585 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.17 -35.71 76.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -76.22 -30.72 58.06 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.398 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.426 HG21 HD23 ' A' ' 81' ' ' LEU . 44.0 t -93.56 1.14 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 C-N-CA 124.311 1.044 . . . . 0.0 109.717 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -42.27 41.04 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 160.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.68 -22.86 61.6 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.19 -4.22 49.42 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.259 14.7 mt -113.63 -61.15 1.78 Allowed 'General case' 0 CA--C 1.458 -2.593 0 CA-C-O 123.571 1.653 . . . . 0.0 109.519 175.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -90.44 -30.76 17.15 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 110.092 -3.231 . . . . 0.0 102.942 -146.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.65 -9.08 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.262 1.719 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 5.5 m-90 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 120.723 0.297 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -150.22 -56.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -172.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.32 1.88 39.09 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -77.62 -41.77 37.33 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 94' ' ' ALA . 6.7 mt -74.51 -43.17 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 C-N-CA 126.558 1.943 . . . . 0.0 108.54 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -61.65 -39.88 92.91 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.79 -26.97 61.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.976 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.87 40.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.88 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.2 -9.64 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 -165.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -78.96 -7.88 58.42 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 122.167 -0.333 . . . . 0.0 111.401 -168.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.4 75.97 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -80.98 -45.84 16.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.63 -12.27 2.94 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 77' ' ' PHE . 37.8 mt -74.54 149.55 40.15 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -123.42 21.76 9.39 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.56 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . 0.254 6.4 t80 85.56 -30.42 0.06 Allowed 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 126.626 1.971 . . . . 0.0 109.075 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 t -80.88 -39.53 26.24 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 118.881 0.764 . . . . 0.0 110.286 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -85.49 -24.21 27.45 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 72' ' ' LEU . 4.9 t80 -66.56 -45.01 80.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -42.6 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 126.451 1.901 . . . . 0.0 109.591 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -50.01 56.53 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-O 121.262 0.553 . . . . 0.0 110.56 -172.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.18 -8.0 84.98 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.683 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB3' ' H ' ' A' ' 87' ' ' GLU 0.32 40.7 mt -62.2 -35.43 78.83 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 118.787 1.294 . . . . 0.0 111.403 166.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -68.88 -37.73 79.21 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -67.64 -33.97 76.02 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.447 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.44 7.7 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.05 31.17 1.46 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.18 -69.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 19.8 tt0 37.93 62.76 0.89 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 128.339 2.656 . . . . 0.0 111.927 -173.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.63 -26.8 2.44 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.764 -164.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 63' ' ' ILE 0.337 0.1 OUTLIER -74.28 142.08 45.28 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.806 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 163.55 -29.65 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.888 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -178.41 123.67 0.1 Allowed 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.466 ' H ' ' HB3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER 76.18 82.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 126.635 1.974 . . . . 0.0 107.708 158.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.317 0.0 OUTLIER 168.33 -33.64 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.954 1 N-CA-C 97.688 -4.93 . . . . 0.0 97.688 -177.88 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 59' ' ' TRP 0.264 . . -55.15 -21.35 13.01 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 111.855 -2.429 . . . . 0.0 111.169 165.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' HA ' HH11 ' A' ' 99' ' ' ARG . 4.5 p-10 -62.59 -50.15 72.44 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -28.2 68.61 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.667 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.89 71.9 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 121.305 -0.872 . . . . 0.0 112.596 -171.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.25 -47.09 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 95' ' ' ASP . 4.5 mpt_? -85.34 -29.19 24.7 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.128 -162.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.49 79.48 54.46 Favored Pre-proline 0 N--CA 1.44 -0.971 0 C-N-CA 123.604 0.761 . . . . 0.0 109.454 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.33 -5.18 14.83 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 122.916 2.411 . . . . 0.0 110.482 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -72.01 -51.49 21.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -36.93 61.2 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -52.38 -43.6 64.81 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.93 -34.6 78.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.201 0.455 . . . . 0.0 110.715 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -67.63 -38.59 84.1 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.68 -43.21 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 t -59.83 -47.89 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 C-N-CA 123.906 0.882 . . . . 0.0 109.31 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -69.04 -28.98 67.04 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 118.209 0.459 . . . . 0.0 111.048 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.7 -31.88 62.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 58.8 t -88.53 -10.47 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 C-N-CA 125.038 1.335 . . . . 0.0 110.598 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -80.8 -25.32 37.93 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.251 7.7 tt0 -91.94 -9.87 41.54 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 111' ' ' VAL . . . -111.21 10.34 21.8 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.261 69.9 mt -76.99 -27.19 54.62 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 102.102 -3.295 . . . . 0.0 102.102 154.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 63.75 47.63 3.55 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.104 -1.862 . . . . 0.0 107.672 -168.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.73 -60.06 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.642 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.525 ' HB2' HD12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.48 -1.718 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.313 0.4 OUTLIER -159.17 -76.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.471 156.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.55 -23.11 16.69 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -171.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' HD3' ' HB1' ' A' ' 94' ' ' ALA . 5.1 ptp180 -74.21 -27.17 60.66 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -93.27 -16.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 123.336 0.654 . . . . 0.0 109.626 -173.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -17.78 31.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.16 -20.78 26.52 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.33 -32.8 29.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 26.8 m -93.45 -6.81 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.747 -164.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -90.19 35.4 0.86 Allowed 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.013 -0.429 . . . . 0.0 111.218 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.26 -36.21 5.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -84.32 -43.96 14.27 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 -167.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.63 -3.71 5.05 Favored Glycine 0 CA--C 1.493 -1.333 0 N-CA-C 107.004 -2.438 . . . . 0.0 107.004 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 68.2 mt -74.15 151.09 40.13 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -124.05 26.16 7.63 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.765 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.5 t80 81.38 -28.03 0.13 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.137 1.775 . . . . 0.0 110.425 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.2 t -78.03 -40.73 37.94 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 123.013 0.525 . . . . 0.0 109.813 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -85.81 -21.73 27.99 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.29 -48.87 77.99 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -42.13 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.569 1.548 . . . . 0.0 110.162 -174.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -46.19 71.8 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-O 121.956 0.884 . . . . 0.0 110.257 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.59 -19.27 79.02 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.382 -174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . 0.286 21.6 mt -62.92 -39.22 93.9 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 119.055 1.428 . . . . 0.0 110.253 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -74.84 -29.98 61.23 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -73.07 -29.44 62.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.36 -52.08 10.63 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 123.653 0.781 . . . . 0.0 109.431 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.09 34.45 1.65 Allowed Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.3 mt -103.52 -58.63 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 22.46 76.65 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 128.893 2.877 . . . . 0.0 112.197 -170.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -126.7 -135.42 0.25 Allowed 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -164.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.1 96.44 0.07 Allowed 'General case' 0 CA--C 1.491 -1.313 0 C-N-CA 125.612 1.565 . . . . 0.0 110.275 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 52.0 ttt85 -160.62 58.69 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 165.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.33 65.8 0.48 Allowed 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 90' ' ' ARG . 8.1 mm -151.07 -53.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 -166.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 63' ' ' ILE 0.271 0.0 OUTLIER -105.72 -29.2 10.23 Favored 'General case' 0 CA--C 1.462 -2.433 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 -170.586 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 91' ' ' LYS 0.267 . . -56.36 -33.75 65.97 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 112.117 -2.311 . . . . 0.0 110.42 168.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -62.3 1.9 Allowed 'General case' 0 N--CA 1.409 -2.523 0 O-C-N 123.924 0.765 . . . . 0.0 109.967 165.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -15.91 63.13 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -167.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.93 90.14 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 120.506 -1.372 . . . . 0.0 110.799 173.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.83 -60.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.5 -24.91 25.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -161.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -124.71 69.67 55.92 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-N 119.139 0.881 . . . . 0.0 111.615 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -75.51 -10.04 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.862 2.374 . . . . 0.0 110.188 -166.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.64 -41.86 71.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.6 -29.4 22.62 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.96 -47.66 67.97 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.928 168.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -69.18 -24.02 64.0 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.835 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -72.64 -32.36 65.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 118.911 0.778 . . . . 0.0 111.274 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.5 t -71.54 -39.11 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.18 -41.18 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -66.79 -37.0 83.71 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 122.021 -0.425 . . . . 0.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.98 -33.6 72.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.528 0.731 . . . . 0.0 110.228 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.7 t -86.79 -21.65 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.05 0 C-N-CA 124.402 1.081 . . . . 0.0 110.005 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -87.89 -8.52 55.69 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.61 -29.81 11.73 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.41 56.42 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 tp -82.06 -32.99 30.11 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 63.75 45.43 4.49 Favored 'General case' 0 CA--C 1.498 -1.019 0 O-C-N 124.874 1.359 . . . . 0.0 108.346 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.05 -7.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.26 1.619 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.558 178.632 . . . . . . . . 0 0 . 1 stop_ save_